Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 66

Sort by

Sort Order Select

Journal Articles

The Expression of TIM3 on Marrow-Infiltrating T Cells Is Increased in Patients with Blood Cancers Who Relapse Early after Hematopoietic Stem Cell Transplantation

Thi Thuy Duong Pham, Su-Young Choi, Buyeon Heo, Sang-Woo Lee, Myung-Won Lee, Jung-Hyun Park, Yunseon Jang, Deog-Yeon Jo, Jaeyul Kwon, Ik Chan Song, Jeong Suk Koh

Blood (2024) 144 (Supplement 1): 3557.

https://doi.org/10.1182/blood-2024-200564

Published: 2024

Journal Articles

Graft-Versus-Host Disease Prophylaxis with Post-Transplant Cyclophosphamide Better Preserves Regulatory T Cell

Jeong Suk Koh, Buyeon Heo, Seul Bi Lee, Su-Young Choi, Thi Thuy Duong Pham, Sang-Woo Lee, Jung-Hyun Park, Yunseon Jang, Wonhyoung Seo, Myung-Won Lee, Deog-Yeon Jo, Jaeyul Kwon, Ik Chan Song

Blood (2024) 144 (Supplement 1): 7371.

https://doi.org/10.1182/blood-2024-209192

Published: 2024

Journal Articles

A Study to Evaluate the Effectiveness and Safety of Prephase Steroid Treatment before Remission Induction Chemotherapy in Patients with Pediatric Acute Lymphoblastic Leukemia Using Common Data Model-Based Real World Data

Yoona Choi, Bo Kyung Kim, Jae Won Yoo, Wona Choi, Jung-Hyun Won, Surin Jung, Jae Yoon Kim, In Young Choi, Nack-Gyun Chung, Jae Wook Lee, Hyoung Jin Kang, Howard Lee

Blood (2023) 142 (Supplement 1): 3791.

https://doi.org/10.1182/blood-2023-185435

Published: 2023

Journal Articles

An Assessment of Marrow-Infiltrating T Cells in Early Relapsed Hematologic Cancer Patients Post Allogeneic Hematopoietic Stem Cell Transplantation

Thi Thuy Duong Pham, Su-Young Choi, Bu-yean Heo, Myung-Won Lee, Jung-Hyun Park, Yunseon Jang, Deog-Yeon Jo, Jaeyul Kwon, Ik Chan Song, Jeong Suk Koh

Blood (2023) 142 (Supplement 1): 4942.

https://doi.org/10.1182/blood-2023-182533

Published: 2023

Journal Articles

Immune-Mediated Limbic Encephalitis after Haplo-Identical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclosphosphamide

Bu-Yeon Heo, Myung-Won Lee, Su-Young Choi, Pham Thi Thuy Duong, Yunseon Jang, Jung-Hyun Park, Deog-Yeon Jo, Jaeyul Kwon, Ik Chan Song

Blood (2022) 140 (Supplement 1): 10480.

https://doi.org/10.1182/blood-2022-168460

Published: 2022

Journal Articles

Exploration of the Appropriate NT-Probnp Level for AL Amyloidosis Staging

Hana Kim, Darae Kim, Jinoh Choi, Eunseok Jeon, Jung Eun Lee, Ju Hong Min, Joon Young Choi, Jung-Sun Kim, Seokjin Kim, Kihyun Kim

Blood (2021) 138 (Supplement 1): 3777.

https://doi.org/10.1182/blood-2021-151675

Published: 2021

Journal Articles

Fyn Specifically Regulates the Activity of Red Cell Glucose-6-Phosphate-Dehydrogenase

Blood (2019) 134 (Supplement_1): 3527.

https://doi.org/10.1182/blood-2019-125709

Published: 2019

Journal Articles

Long-Term Follow-up after Treatment Discontinuation in Patients with Chronic Myeloid Leukemia: The Korean Imatinib Discontinuation (KID) Study

Dae Young Zang, MD PhD, Won Sik Lee, MD PhD, Yeung-Chul Mun, Young Rok Do, PhD MD, Sukjoong Oh, MD PhD, Sung-Eun Lee, MD PhD, Soo Young Choi, Dong-Wook Kim, MD PhD

Blood (2018) 132 (Supplement 1): 4252.

https://doi.org/10.1182/blood-2018-99-118026

Published: 2018

Journal Articles

Association of Gene Expression Patterns in Bone Marrow Cells with Likelihood of Treatment Free Remission after TKI Discontinuation

Jianbo He, MD, Sahee Park, Soo Young Choi, David Crossman, Bin Zhang, PhD, Puneet Agarwal, PhD, Andrew Zhang, Su Chu, MD, Dong-Wook Kim, MD PhD, Ravi Bhatia, MD

Blood (2018) 132 (Supplement 1): 1721.

https://doi.org/10.1182/blood-2018-99-114137

Published: 2018

Journal Articles

Inpatient Mortality and Length of Stay Among Direct-Acting Oral Anticoagulant (DOAC) and Warfarin Users Presenting with Major Hemorrhage

Walter Bialkowski, PhD MS, Sylvia Tan, MS, Alan E. Mast, MDPhD, Joseph Kiss, MD, Daryl J. Kor, MD MSc, Jerome Gottschall, MD, Yanyun Wu, MD PhD, Nareg H. Roubinian, MD, Darrell Triulzi, MD, Steven Kleinman, MD, Young Choi, MD, Donald Brambilla, PhD, Ann Butler Zimrin, MD, The NHLBI Recipient Epidemiology and Donor Evaluation Study-III

Blood (2018) 132 (Supplement 1): 2538.

https://doi.org/10.1182/blood-2018-99-112631

Published: 2018

Journal Articles

Bortezomib-Based First Line Treatment for AL Amyloidosis Patients Who Are Not Candidate for Stem Cell Transplantaion

Joon Young Hur, MD, Kang Kook Lee, MD, Sang Eun Yoon, MD, Sehhoon Park, MD, Jangho Cho, MD, Youjin Kim, MD, Eunseok Jeon, MD PhD, Jinoh Choi, MD PhD, Gayeon Lee, MD PhD, Byungjun Kim, MD PhD, Ju Hong Min, MD PhD, Jung Sun Kim, MD PhD, Jung Eun Lee, MD PhD, Joon Young Choi, MD PhD, Seok Jin Kim, MD PhD, Jun Ho Jang, MD PhD, Won-Seog Kim, MD PhD, Chul Won Jung, MD PhD, Kihyun Kim, MD PhD

Blood (2018) 132 (Supplement 1): 3256.

https://doi.org/10.1182/blood-2018-99-114099

Published: 2018

Journal Articles

Prognostic Implication of Early Molecular Response at 3 Months in Chronic Myeloid Leukemia Patients: A Comparison of Imatinib and Second Generation Tyrosine Kinase Inhibitors

Dong-Wook Kim, MD PhD, Sung-Eun Lee, MD PhD, Soo Young Choi, Dae Young Zang, MD PhD, Won-Sik Lee, Yeung-Chul Mun, Young Rok Do, PhD MD, Sukjoong Oh, MD PhD

Blood (2018) 132 (Supplement 1): 3017.

https://doi.org/10.1182/blood-2018-99-117631

Published: 2018

Journal Articles

Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease

Blood (2018) 132 (9): 948–961.

https://doi.org/10.1182/blood-2018-02-832253

Published: 2018

Includes: Supplemental data

Journal Articles

The Role of Matrix Metalloproteinase-9 in Monocytic Myeloid-Derived Suppressor Cells in Allogeneic Hematopoietic Stem Cell Transplantation

Sung-Eun Lee, MD, Ji-Young Lim, Tae Woo Kim, Young-Woo Jeon, MD, Jae-Ho Yoon, MD PhD, Byung-Sik Cho, MD, Ki-Seong Eom, Yoo-Jin Kim, MD PhD, Hee-Je Kim, Seok Lee, Seok-Goo Cho, Dong-Wook Kim, MD PhD, Jong-Wook Lee, MD, Woo-Sung Min, Dong-Mi Shin, Eun Young Choi, Chang-Ki Min, MD

Blood (2017) 130 (Supplement 1): 3234.

https://doi.org/10.1182/blood.V130.Suppl_1.3234.3234

Published: 2017

Journal Articles

Efficacy of Bortezomib-Based Regimens for Patients with Newly Diagnosed AL Amyloidosis Not Receiving ASCT Compared with Alkylators and Dexamethasone-Based Regimens

Blood (2017) 130 (Supplement 1): 3114.

https://doi.org/10.1182/blood.V130.Suppl_1.3114.3114

Published: 2017

Journal Articles

Mir-424 and Mir-503 Regulates Cobll1 Expression during the CML Progression

Seung Hun Han, PhD, Soo-Hyun Kim, Kim Hyoung-June, PhD, Lee Yoonsung, PhD, Soo-Young Choi, Park Gyeongsin, Kim Do-Hyun, Lee Aram, Kim Jongmin, PhD, Choi Je-Min, PhD, Kim Yonghwan, PhD, Myung Kyungjae, PhD, Kim Hongtae, PhD, Dong-Wook Kim, MD PhD

Blood (2017) 130 (Supplement 1): 4177.

https://doi.org/10.1182/blood.V130.Suppl_1.4177.4177

Published: 2017

Journal Articles

Integrative Genomics Reveals Cancer Associated Mutations Are Common at Diagnosis of CML in Patients with Poor Response to TKI Therapy

Blood (2017) 130 (Supplement 1): 251.

https://doi.org/10.1182/blood.V130.Suppl_1.251.251

Published: 2017

Journal Articles

Prevalence and Risk Predictive Factors of Comorbid Malignancies in Patients with Chronic Myeloid Leukemia

Tong-Yoon Kim, MD, Sung-Eun Lee, Soo-Hyun Kim, Soo-Young Choi, Eun-Jung Jang, Dong-Wook Kim, MD PhD

Blood (2016) 128 (22): 1900.

https://doi.org/10.1182/blood.V128.22.1900.1900

Published: 2016

Journal Articles

Predictive Value of 3-Month Early Molecular Response in New Chronic Phase Chronic Myeloid Leukemia Patients Treated with Radotinib

Blood (2015) 126 (23): 4053.

https://doi.org/10.1182/blood.V126.23.4053.4053

Published: 2015

NARROW

The Expression of TIM3 on Marrow-Infiltrating T Cells Is Increased in Patients with Blood Cancers Who Relapse Early after Hematopoietic Stem Cell Transplantation

Graft-Versus-Host Disease Prophylaxis with Post-Transplant Cyclophosphamide Better Preserves Regulatory T Cell

A Study to Evaluate the Effectiveness and Safety of Prephase Steroid Treatment before Remission Induction Chemotherapy in Patients with Pediatric Acute Lymphoblastic Leukemia Using Common Data Model-Based Real World Data

An Assessment of Marrow-Infiltrating T Cells in Early Relapsed Hematologic Cancer Patients Post Allogeneic Hematopoietic Stem Cell Transplantation

Immune-Mediated Limbic Encephalitis after Haplo-Identical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclosphosphamide

Exploration of the Appropriate NT-Probnp Level for AL Amyloidosis Staging

Fyn Specifically Regulates the Activity of Red Cell Glucose-6-Phosphate-Dehydrogenase

Long-Term Follow-up after Treatment Discontinuation in Patients with Chronic Myeloid Leukemia: The Korean Imatinib Discontinuation (KID) Study

Association of Gene Expression Patterns in Bone Marrow Cells with Likelihood of Treatment Free Remission after TKI Discontinuation

Inpatient Mortality and Length of Stay Among Direct-Acting Oral Anticoagulant (DOAC) and Warfarin Users Presenting with Major Hemorrhage

Bortezomib-Based First Line Treatment for AL Amyloidosis Patients Who Are Not Candidate for Stem Cell Transplantaion

Prognostic Implication of Early Molecular Response at 3 Months in Chronic Myeloid Leukemia Patients: A Comparison of Imatinib and Second Generation Tyrosine Kinase Inhibitors

Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease

The Role of Matrix Metalloproteinase-9 in Monocytic Myeloid-Derived Suppressor Cells in Allogeneic Hematopoietic Stem Cell Transplantation

Efficacy of Bortezomib-Based Regimens for Patients with Newly Diagnosed AL Amyloidosis Not Receiving ASCT Compared with Alkylators and Dexamethasone-Based Regimens

Mir-424 and Mir-503 Regulates Cobll1 Expression during the CML Progression

Integrative Genomics Reveals Cancer Associated Mutations Are Common at Diagnosis of CML in Patients with Poor Response to TKI Therapy

Comparison of Molecular Kinetics after the First and Second Imatinib Discontinuation: Results from the KID Study

Prevalence and Risk Predictive Factors of Comorbid Malignancies in Patients with Chronic Myeloid Leukemia

Predictive Value of 3-Month Early Molecular Response in New Chronic Phase Chronic Myeloid Leukemia Patients Treated with Radotinib

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only